Credit: Getty Images. Shionogi has announced positive results from the phase 3 APEKS-NP trial of cefiderocol (S-649266) for the treatment of nosocomial pneumonia. Shionogi has announced positive ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

In a study, IV fosfomycin appeared less effective than IV ceftriaxone or meropenem for bacteremic UTI caused by multidrug-resistant E. coli, but the drug may be considered for selected patients with ...

Meropenem 0.5-g a and 1-g b vials were used to prepare 4-mg/mL solutions. Each 0.5-g vial was reconstituted with 10 mL of sterile water for injection (SWFI) and each 1-g vial with 20 mL of SWFI to ...

Amneal Biosciences announced the launch of Meropenem for Injection, the generic version of AstraZeneca's Merrem. The bactericidal activity of meropenem results from the inhibition of cell wall ...